Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine versus propofol for rapid sequence intubation in critically ill ICU patients
ChiCTR2600132907Phase 4Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine and propofol in critical illness (2 arms), sponsored by Union Hospital. Primary endpoint: Minimum mean arterial pressure. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
esketaminepropofol
03
Conditions
critical illness
Beyond the preview
Go deeper on ChiCTR2600132907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132907.